A detailed history of Hantz Financial Services, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 2,202 shares of VTRS stock, worth $27,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,202
Previous 2,170 1.47%
Holding current value
$27,569
Previous $23,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $330 - $388
32 Added 1.47%
2,202 $26,000
Q2 2024

Jul 30, 2024

BUY
$10.05 - $12.02 $21,808 - $26,083
2,170 New
2,170 $23,000
Q1 2024

Aug 06, 2024

BUY
$11.27 - $13.53 $529 - $635
47 Added 2.36%
2,035 $24,000
Q4 2023

Aug 06, 2024

SELL
$8.77 - $10.85 $1,175 - $1,453
-134 Reduced 6.31%
1,988 $22,000
Q3 2023

Aug 06, 2024

BUY
$9.59 - $11.35 $700 - $828
73 Added 3.56%
2,122 $21,000
Q2 2023

Aug 06, 2024

SELL
$9.02 - $10.29 $225 - $257
-25 Reduced 1.21%
2,049 $20,000
Q1 2023

Aug 06, 2024

BUY
$9.2 - $12.26 $524 - $698
57 Added 2.83%
2,074 $20,000
Q4 2022

Aug 06, 2024

BUY
$8.72 - $11.56 $34 - $46
4 Added 0.2%
2,017 $22,000
Q3 2022

Aug 06, 2024

BUY
$8.48 - $11.13 $33 - $44
4 Added 0.2%
2,013 $17,000
Q2 2022

Aug 06, 2024

SELL
$9.95 - $12.27 $1,034 - $1,276
-104 Reduced 4.92%
2,009 $21,000
Q1 2022

Aug 06, 2024

BUY
$9.81 - $15.4 $225 - $354
23 Added 1.1%
2,113 $23,000
Q4 2021

Aug 06, 2024

SELL
$12.09 - $14.68 $2,212 - $2,686
-183 Reduced 8.05%
2,090 $28,000
Q3 2021

Aug 06, 2024

BUY
$13.25 - $15.13 $212 - $242
16 Added 0.71%
2,273 $31,000
Q2 2021

Aug 06, 2024

SELL
$12.97 - $16.15 $324 - $403
-25 Reduced 1.1%
2,257 $32,000
Q1 2021

Aug 06, 2024

BUY
$13.59 - $18.54 $1,522 - $2,076
112 Added 5.16%
2,282 $32,000
Q4 2020

Aug 06, 2024

BUY
$14.3 - $18.74 $4,104 - $5,378
287 Added 13.23%
2,457 $46,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.